Loading…
Based on limited metadata, this FDA Warning Letter was issued to Tri-Coast Pharmacy on August 20, 2018, regarding compliance issues with pharmacy operations. While the specific violations and regulatory details are not available in the provided metadata, the letter indicates that the FDA identified concerns significant enough to warrant formal enforcement action. Without access to the complete warning letter text, the exact nature of the violations and the specific regulatory requirements at issue cannot be determined, though they likely relate to pharmacy practice standards, product handling, or operational compliance within FDA's purview.